Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/eja.0b013e32831f3475 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Peripheral Mechanisms Underlying Bacillus Calmette-Guerin-Induced Lower Urinary Tract Symptoms (LUTS).
Brain Sci
November 2024
Flinders Health and Medical Research Institute (FHMRI), College of Medicine and Public Health, Flinders University, Adelaide 5042, Australia.
Non-muscle invasive bladder cancer (NMIBC) accounts for approximately 70-75% of all bladder cancer cases. The standard treatment for high-risk NMIBC involves transurethral tumour resection followed by intravesical Bacillus Calmette-Guerin (BCG) immunotherapy. While BCG immunotherapy is both safe and effective, it frequently leads to the development of lower urinary tract symptoms (LUTS) such as urinary urgency, frequency, dysuria, and pelvic discomfort.
View Article and Find Full Text PDFRe: Purushothaman J, Kalra S, Dorairajan LN, Selvarajan S, Sreerag KS, Aggarwal D. Intravesical bupivacaine in reducing catheter-related bladder discomfort and lower urinary tract symptoms after transurethral surgery: A randomized controlled trial. Indian J Urol 2024;40:161-6.
Indian J Urol
October 2024
Department of Urology, AIIMS, Bhubaneswar, Odisha, India.
Author reply Re: Purushothaman J, Kalra S, Dorairajan LN, Selvarajan S, Sreerag KS, Aggarwal D. Intravesical bupivacaine in reducing catheter-related bladder discomfort and lower urinary tract symptoms after transurethral surgery: A randomized controlled trial. Indian J Urol 2024;40:161-6.
Indian J Urol
October 2024
Department of Urology and Renal Transplant, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Correction to: Effects of an intraoperative intravenous Bolus Dose of Dexmedetomidine on postoperative catheter-related bladder discomfort in male patients undergoing transurethral resection of bladder tumors: a randomized, double-blind, controlled trial.
Eur J Clin Pharmacol
January 2025
Department of Anesthesiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Holmium laser enucleation of the prostate with transurethral intraprostatic anesthesia using Schelin catheter: a preliminary communication.
Cent European J Urol
April 2024
Department of Urology, Policlinico Abano Terme, Abano Terme, Italy.
Introduction: This study was aimed to evaluate the feasibility, safety, and advantages of the use of transurethral intraprostatic anesthesia (TUIA) using Schelin Catheter (SC) in patients undergoing holmium laser enucleation of the prostate (HoLEP).
Material And Methods: TUIA was performed using SC, a catheter equipped with an operative channel with a retractile needle, a standard drainage outlet, and a balloon port. After inserting the SC into the patient's urethra and filling the balloon to anchor it in the bladder neck, four target injections with local anesthetic were performed, one in each quadrant in the base area of the prostate.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!